Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.60 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.60 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.60 |
| ▸ | TST | Q16762 | 1/20 | 0.60 |
| ▸ | RECQL | P46063 | 1/20 | 0.60 |
| ▸ | BLM | P54132 | 1/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
| ▸ | TYR | P14679 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | PRKCA | P17252 | 9/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL874725 | 1.00 | MAPT (0.60) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL15364 | 1.00 | MAPT (0.60) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL16950234 | 1.00 | MAPT (0.60) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL936066 | 1.00 | MAPT (0.60) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL875292 | 1.00 | MAPT (0.60) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL444603 | 1.00 | MAPT (0.60) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL16201 | 1.00 | MAPT (0.60) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL875399 | 1.00 | MAPT (0.60) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL22730055 | 1.00 | MAPT (0.60) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL875356 | 1.00 | MAPT (0.60) | MAPTHSPD1HSPE1TSTRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230293410-A1 | Compositions Comprising Lipophilic Compounds and One or More (Bio)-Alkanediols | SYMRISE AG (DE) | 2023-09-21 | — | — | US | disclosed |
| EP-3316856-A1 | BLENDED FORMULATIONS | Sequessome Technology Holdings Limited (MT) | 2018-05-09 | — | — | EP | disclosed |
| WO-2017001617-A1 | BLENDED FORMULATIONS | SEQUESSOME TECHNOLOGY HOLDINGS LIMITED (MT) | 2017-01-05 | — | — | WO | disclosed |
| EP-2892616-A2 | COSMETIC COMPOSITIONS COMPRISING EICOSAPENTAENINIC FREE ACID AND GAMMA-LINOPENIC FREE ACID AND METHODS OF MAKING AND USING SAME | Dignity Sciences Limited (IE) | 2015-07-15 | — | — | EP | disclosed |
| EP-2822660-A2 | COMPOSITION FOR TREATING SKIN PIGMENTATION | Lonza Walkersville, Inc. (US) | 2015-01-14 | — | — | EP | disclosed |
| WO-2014037903-A2 | COSMETIC COMPOSITIONS COMPRISING EPA AND GLA AND METHODS OF MAKING AND USING SAME | DIGNITY SCIENCES, LTD. (IE) | 2014-03-13 | — | — | WO | disclosed |
| WO-2013092973-A2 | COMPOSITION FOR TREATING SKIN PIGMENTATION | LONZA WALKERSVILLE INC. (US) | 2013-06-27 | — | — | WO | disclosed |
| EP-2473159-A2 | A COMPOSITION FOR DELAYING CELLULAR SENESCENCE | Arch Personal Care Products, L.P. (US) | 2012-07-11 | — | — | EP | disclosed |
| WO-2011028673-A2 | A COMPOSITION FOR DELAYING CELLULAR SENESCENCE | ARCH PERSONAL CARE PRODUCTS, L.P. (US) | 2011-03-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230293410-A1 | Compositions Comprising Lipophilic Compounds and One or More (Bio)-Alkanediols | TRPA1, CUTA, OR51E2 | MAPT 1575/4885HSPD1 3664/4885HSPE1 3851/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.